Concepts (75)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biofilms | 6 | 2003 | 23 | 0.690 |
Why?
|
| Candida albicans | 5 | 2003 | 13 | 0.660 |
Why?
|
| Herpesvirus 2, Human | 1 | 2018 | 2 | 0.580 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2018 | 2 | 0.580 |
Why?
|
| Herpesvirus 1, Human | 1 | 2018 | 8 | 0.580 |
Why?
|
| Viral Load | 1 | 2018 | 73 | 0.570 |
Why?
|
| Antifungal Agents | 5 | 2003 | 41 | 0.510 |
Why?
|
| Fluconazole | 4 | 2003 | 8 | 0.430 |
Why?
|
| Amphotericin B | 4 | 2003 | 12 | 0.430 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 11 | 0.350 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2021 | 22 | 0.350 |
Why?
|
| Glucocorticoids | 1 | 2021 | 151 | 0.320 |
Why?
|
| Peptides, Cyclic | 3 | 2003 | 4 | 0.300 |
Why?
|
| Peptides | 3 | 2003 | 125 | 0.240 |
Why?
|
| Anti-Bacterial Agents | 3 | 2020 | 332 | 0.230 |
Why?
|
| Child, Preschool | 3 | 2021 | 1282 | 0.210 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2002 | 4 | 0.190 |
Why?
|
| Fungal Proteins | 1 | 2002 | 9 | 0.190 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 142 | 0.180 |
Why?
|
| Polystyrenes | 1 | 2001 | 3 | 0.180 |
Why?
|
| Candida | 1 | 2001 | 7 | 0.180 |
Why?
|
| Polymethyl Methacrylate | 1 | 2001 | 12 | 0.180 |
Why?
|
| Transcription Factors | 1 | 2002 | 176 | 0.180 |
Why?
|
| beta-Lactamases | 1 | 2020 | 13 | 0.160 |
Why?
|
| Klebsiella pneumoniae | 1 | 2020 | 14 | 0.160 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2020 | 35 | 0.160 |
Why?
|
| Child | 2 | 2021 | 2478 | 0.150 |
Why?
|
| Acyclovir | 1 | 2018 | 14 | 0.140 |
Why?
|
| Microbial Sensitivity Tests | 4 | 2020 | 79 | 0.140 |
Why?
|
| DNA, Viral | 1 | 2018 | 54 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 1 | 2018 | 199 | 0.140 |
Why?
|
| Adolescent | 2 | 2021 | 3640 | 0.130 |
Why?
|
| Infant, Newborn | 1 | 2018 | 694 | 0.120 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 881 | 0.110 |
Why?
|
| Infant | 1 | 2018 | 1083 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 1307 | 0.090 |
Why?
|
| Colorimetry | 2 | 2002 | 3 | 0.090 |
Why?
|
| Brain | 1 | 2018 | 946 | 0.090 |
Why?
|
| Young Adult | 1 | 2018 | 2734 | 0.090 |
Why?
|
| Immunomodulation | 1 | 2021 | 29 | 0.090 |
Why?
|
| Propensity Score | 1 | 2021 | 48 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2021 | 148 | 0.090 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 65 | 0.090 |
Why?
|
| Regression Analysis | 1 | 2021 | 288 | 0.080 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 98 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 289 | 0.080 |
Why?
|
| Male | 3 | 2021 | 19650 | 0.080 |
Why?
|
| Humans | 5 | 2021 | 32814 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2002 | 767 | 0.080 |
Why?
|
| Echinocandins | 3 | 2003 | 6 | 0.070 |
Why?
|
| Lipopeptides | 3 | 2003 | 6 | 0.070 |
Why?
|
| Hospitalization | 1 | 2021 | 488 | 0.070 |
Why?
|
| Female | 2 | 2021 | 20271 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2021 | 1844 | 0.060 |
Why?
|
| Tetrazolium Salts | 2 | 2003 | 5 | 0.060 |
Why?
|
| Adult | 1 | 2018 | 9569 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2021 | 3441 | 0.050 |
Why?
|
| Colony Count, Microbial | 1 | 2002 | 18 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2002 | 14 | 0.050 |
Why?
|
| Coloring Agents | 1 | 2002 | 30 | 0.050 |
Why?
|
| Culture Media | 1 | 2002 | 45 | 0.050 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2002 | 94 | 0.050 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2001 | 9 | 0.040 |
Why?
|
| Candidiasis, Oral | 1 | 2001 | 10 | 0.040 |
Why?
|
| Plasma | 1 | 2001 | 14 | 0.040 |
Why?
|
| Cell Count | 1 | 2001 | 48 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2001 | 71 | 0.040 |
Why?
|
| Saliva | 1 | 2001 | 39 | 0.040 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 1 | 2020 | 3 | 0.040 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2020 | 47 | 0.040 |
Why?
|
| Models, Biological | 1 | 2001 | 392 | 0.040 |
Why?
|
| Time Factors | 1 | 2002 | 2183 | 0.030 |
Why?
|
| United States | 1 | 2020 | 4109 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2003 | 99 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 30 | 0.010 |
Why?
|